<turbo-stream action="append" target="audio_clips_list"><template>
    <hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7682491-giri-and-gomella-on-fostering-a-new-framework-for-genetic-testing-guidelines-in-prostate-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep38: Giri and Gomella on Fostering a New Framework for Genetic Testing Guidelines in Prostate Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Giri and Dr. Gomella discuss the rationale to create the first multidisciplinary, consensus-driven framework for prostate cancer genetic testing, the importance of having a multidisciplinary team weigh in on the recommendations, and key aspects of the guidelines that could have clinical implications for men in this space.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
35m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1600117178" data-format="short_date">Sep 14, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
35m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7679852-tolaney-talks-tailored-treatment-strategies-in-her2-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep37: Tolaney Talks Tailored Treatment Strategies in HER2+ Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Sara M. Tolaney, MD, MPH, shared insight on how risk status is being used to tailor HER2-directed therapies to patients with early-stage HER2-positive breast cancer, key trials focused on delineating optimal deescalated and escalated treatment strategies, and ongoing research in the HER2-low setting.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
16m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1599765653" data-format="short_date">Sep 10, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
16m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7674262-herzog-and-moore-mull-over-the-role-of-maintenance-parp-inhibition-in-ovarian-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep36: Herzog and Moore Mull Over the Role of Maintenance PARP Inhibition in Ovarian Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Herzog and Dr. Moore reviewed the topline results of the 4 positive PARP inhibitor trials in the frontline maintenance setting and provided perspective on the potential applications of these data to clinical practice.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
30m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1599504000" data-format="short_date">Sep 07, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
30m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7674256-coleman-and-slomovitz-continue-the-discussion-on-maintenance-parp-inhibition-in-ovarian-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep35: Coleman and Slomovitz Continue the Discussion on Maintenance PARP Inhibition in Ovarian Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Coleman and Dr. Slomovitz discussed the benefits and limitations of PARP inhibition in all-comers with newly diagnosed advanced ovarian cancer and pivotal PARP inhibitor trials in the frontline setting.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
28m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1599158747" data-format="short_date">Sep 03, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
28m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7671639-gu-experts-review-treatment-options-remaining-challenges-and-future-research-in-penile-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep34: GU Experts Review Treatment Options, Remaining Challenges, and Future Research in Penile Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
Today, we had the pleasure of sitting down with a group of experts in genitourinary cancers from Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Moffitt Cancer Center to discuss a malignancy that is not often an everyday focus: penile cancer. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
27m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1598904213" data-format="short_date">Aug 31, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
27m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7668714-fda-approval-insights-avelumab-in-metastatic-urothelial-carcinoma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep33: FDA Approval Insights: Avelumab in Metastatic Urothelial Carcinoma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Shilpa Gupta, MD, of Cleveland Clinic, discusses the FDA approval of avelumab in metastatic urothelial carcinoma and key findings from the JAVELIN Bladder 100 study.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
12m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1598554500" data-format="short_date">Aug 27, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
12m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7665787-talking-tumors-evaluating-early-stage-breast-cancer-cases-in-the-covid-19-era"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep32: Talking Tumors: Evaluating Early-Stage Breast Cancer Cases in the COVID-19 Era
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Meisel and Dr. Hamilton provided insight on key data from the 2020 ASCO Virtual Scientific Program and best practices in managing patients during the coronavirus disease 2019 pandemic.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
25m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1598298639" data-format="short_date">Aug 24, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
25m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7662586-talking-kras-targeted-therapy-in-nsclc-with-dr-levy"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep31: Talking KRAS-Targeted Therapy in NSCLC With Dr. Levy
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Levy discusses the challenges of targeting KRAS and highlighted some of the investigational agents directed toward KRAS G12C mutations that have emerged in the NSCLC pipeline.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
12m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1597951347" data-format="short_date">Aug 20, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
12m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7659905-pegram-unpacks-pivotal-data-in-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep30: Pegram Unpacks Pivotal Data in Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Pegram discusses the unique structure of trastuzumab deruxtecan, initial and subset analyses from the DESTINY-Breast01 trial, and potential adverse effects and recommended management strategies for the agent.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
20m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1597688073" data-format="short_date">Aug 17, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
20m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7657437-research-reflections-braunstein-breaks-down-top-asco-2020-abstracts-in-myeloma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep29: Research Reflections: Braunstein Breaks Down Top ASCO 2020 Abstracts in Myeloma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Marc J. Braunstein, MD, PhD, provided perspective on data in the up-front and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
39m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1597347087" data-format="short_date">Aug 13, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
39m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7654587-markman-and-monk-provide-perspective-on-the-utility-of-parp-inhibitors-in-ovarian-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep28: Markman and Monk Provide Perspective on the Utility of PARP Inhibitors in Ovarian Cancer 
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Bradley J. Monk, MD, FACS, FACOG, and Maurie Markman, MD, discuss the rationale behind maintenance therapy, pivotal PARP inhibitor trials in the frontline setting, and the importance of shared-decision making. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
19m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1597084598" data-format="short_date">Aug 10, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
19m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7651129-dizon-discusses-elements-of-sexual-health-in-gynecologic-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep27: Dizon Discusses Elements of Sexual Health in Gynecologic Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Don. S. Dizon, MD, FACP, FASCO, discusses the primary physical and residual psychological effects of gynecologic cancers on women’s sexual health, the challenges of broaching these topics in the clinic, and the role oncologists play in helping patients manage these difficulties.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
21m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1596736083" data-format="short_date">Aug 06, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
21m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7648463-fda-approval-insights-brexucabtagene-autoleucel-in-relapsed-refractory-mcl"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep26: FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory MCL
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In an interview with OncLive, Dr. Wang discusses the FDA approval of brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma and ongoing research aimed at optimizing the safety and persistence of the product.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
15m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1596485082" data-format="short_date">Aug 03, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
15m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7640647-dinardo-discusses-viale-a-and-venetoclax-combo-in-aml"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep25: DiNardo Discusses VIALE-A and Venetoclax Combo in AML
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. DiNardo discussed the role of venetoclax in AML and explained the significance of the results of the VIALE-A trial.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
11m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1596135600" data-format="short_date">Jul 30, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
11m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7640642-talking-kras-targeted-therapy-in-nsclc-with-dr-riess"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep24: Talking KRAS-Targeted Therapy in NSCLC With Dr. Riess
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Riess discussed the excitement surrounding KRAS G12C inhibitors in NSCLC, preliminary efficacy and safety data with AMG 510, and additional research regarding co-mutations and combinations that could lead to further refinement of the potential role of the agent in the landscape.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
11m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1595876400" data-format="short_date">Jul 27, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
11m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7639709-examining-adaura-and-the-advantages-of-adjuvant-osimertinib-in-egfr-nsclc"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep23: Examining ADAURA and the Advantages of Adjuvant Osimertinib in EGFR+ NSCLC
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Aggarwal, Dr. Sequist, and Dr. Pennell provided perspective on the results of the ADAURA trial and addressed the potential clinical and financial concerns of using osimertinib in the adjuvant setting in patients with EGFR-mutant non–small cell lung cancer.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
26m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1595536041" data-format="short_date">Jul 23, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
26m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7637012-fda-approval-insights-selpercatinib-in-ret-nsclc-and-thyroid-cancers"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep22: FDA Approval Insights: Selpercatinib in RET+ NSCLC and Thyroid Cancers
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Drilon provided background on use of targeted therapy in advanced NSCLC, discussed the frequency of RET alterations, and expanded on the data from the LIBRETTO-001 trial that led to the accelerated approval of selpercatinib.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
12m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1595275737" data-format="short_date">Jul 20, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
12m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7634467-research-reflections-sarcoma-experts-consider-emerging-evidence-for-novel-combos"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep21: Research Reflections: Sarcoma Experts Consider Emerging Evidence for Novel Combos
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Sen and Dr. Groisberg highlight research evaluating checkpoint inhibitors and combination chemotherapy regimens in the evolving sarcoma treatment paradigm.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
49m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1594930165" data-format="short_date">Jul 16, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
49m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7631278-first-of-its-kind-mmrf-curecloud-makes-way-for-precision-medicine-in-myeloma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep20: First of its Kind MMRF CureCloud Makes Way for Precision Medicine in Myeloma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Cho and Dr. Ghobrial discuss the inspiration for the MMRF CureCloud, how it advances precision medicine, and the long-term goals of the study for patients and physicians alike.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
33m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1594672825" data-format="short_date">Jul 13, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
33m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7628773-marvels-in-medicine-dr-jordan-on-undertaking-an-unforeseen-career-in-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep19: Marvels in Medicine: Dr. Jordan on Undertaking an Unforeseen Career in Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Jordan explains how he became “The Father of Tamoxifen,” details his work with British Special Forces during the Cold War, and discusses how his career in science started by setting his parents’ house on fire.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
40m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1594328400" data-format="short_date">Jul 09, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
40m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7624374-fda-approval-insights-ramucirumab-erlotinib-in-egfr-metastatic-nsclc"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep18:  FDA Approval Insights: Ramucirumab/Erlotinib in EGFR+ Metastatic NSCLC
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Edgardo S. Santos, MD, discusses the data that led to the approval of ramucirumab in combination with erlotinib and shares his thoughts on its utility in the frontline setting.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
18m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1594056191" data-format="short_date">Jul 06, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
18m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7621947-talking-kras-targeted-therapy-in-nsclc-with-dr-drilon"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep17: Talking KRAS-Targeted Therapy in NSCLC With Dr. Drilon
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Alexander Drilon, MD, discusses some of the historical challenges of targeting KRAS and provided perspective on available and anticipated data with AMG 510 in non–small cell lung cancer.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
12m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1593718340" data-format="short_date">Jul 02, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
12m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7619205-research-reflections-weinberg-weighs-in-on-thought-provoking-data-in-crc"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep16: Research Reflections: Weinberg Weighs in on Thought-Provoking Data in CRC
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Weinberg, shares the clinical implications of these data in the treatment of patients with CRC and projected what the future may hold in the space.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
28m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1593468019" data-format="short_date">Jun 29, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
28m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7616575-fda-approval-insights-olaparib-in-hrr-mutant-mcrpc"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep15: FDA Approval Insights: Olaparib in HRR-Mutant mCRPC
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Agarwal, who was also a member of the PROfound trial Global Steering Committee, discussed the approval of olaparib in HRR-mutant mCRPC, key efficacy and safety data from the PROfound trial, the importance of genomic sequencing in the metastatic setting, and ongoing research with PARP inhibitors in earlier lines of therapy.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
24m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1593110505" data-format="short_date">Jun 25, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
24m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7613813-marvels-in-medicine-vokes-s-venture-to-bring-combined-modality-care-to-patients-with-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep14: Marvels in Medicine: Vokes’s Venture to Bring Combined Modality Care to Patients With Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Vokes discussed the path that led him to specialize in head and neck cancer and lung cancer, personal and professional challenges he encountered along the way, and the ultimate importance of bringing multimodality therapy to the forefront of treatment.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
22m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1592855337" data-format="short_date">Jun 22, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
22m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7611144-integrating-nutrition-into-the-continuum-of-cancer-care"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep13: Integrating Nutrition Into the Continuum of Cancer Care
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Hegazi, medical director of Adult Nutrition at Abbott, shed light on nutrition-related issues among patients with cancer, early intervention strategies for patients who experience loss of muscle mass and function, and the use of specialized nutrients to prevent muscle degradation.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
24m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1592508463" data-format="short_date">Jun 18, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
24m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7608156-fda-approval-insights-nivolumab-ipilimumab-in-advanced-nsclc"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep12: FDA Approval Insights: Nivolumab/Ipilimumab in Advanced NSCLC
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Ramalingam, who is also a professor in the Department of Hematology and Medical Oncology and the Roberto C. Goizueta Distinguished Chair for Cancer Research at Emory University School of Medicine, shed light on key findings from the CheckMate-227 trial. He also discussed the impact of the approval on other frontline treatment regimens in the metastatic setting an...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
11m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1592245944" data-format="short_date">Jun 15, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
11m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7605460-marvels-in-medicine-dr-gradishar-on-the-personal-pursuit-of-precision-medicine-in-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep11: Marvels in Medicine: Dr. Gradishar on the Personal Pursuit of Precision Medicine in Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Gradishar shared the path that led him to specialize in the field of breast cancer, collective experiences that have inspired him throughout his career, and his hope for the continued transition from “shotgun medicine” to precision medicine in the field.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
15m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1591902607" data-format="short_date">Jun 11, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
15m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7602425-research-reflections-hamid-homes-in-on-key-efforts-made-in-melanoma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep10: Research Reflections: Hamid Homes in on Key Efforts Made in Melanoma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Hamid, director of the Melanoma Center and Phase I Immuno-Oncology Program and chief of Immunotherapy and Translational Research at The Angeles Clinic and Research Institute, highlighted key abstracts in melanoma as they relate to the optimal duration and sequencing of checkpoint inhibitors, adoptive cell therapy, and subgroups of patients with mucosal melanoma a...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
14m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1591653657" data-format="short_date">Jun 08, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
14m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7599471-reviewing-the-risk-benefit-ratio-of-adjuvant-and-neoadjuvant-approaches-in-melanoma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep9: Reviewing the Risk-Benefit Ratio of Adjuvant and Neoadjuvant Approaches in Melanoma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Luke and Dr. Davar discuss the evolution of adjuvant therapy in melanoma from interferon alpha to checkpoint inhibition to targeted therapy, the potential advantages of neoadjuvant therapy, and the relative risk-benefit ratio of using these agents in the curative setting.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
32m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1591300042" data-format="short_date">Jun 04, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
32m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7596530-chowdhary-covers-risk-reducing-strategies-and-recommendations-during-the-covid-19-era"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep8: Chowdhary Covers Risk-Reducing Strategies and Recommendations During the COVID-19 Era
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Chowdhary, a chief resident physician of Radiation Oncology at Rush University Medical Center, shared advice for family members living with patients with cancer, projected the long-term implications of the COVID-19 pandemic on clinical practice, provided insight on the effects of investigational treatments for patients with COVID-19, and detailed the protocols Ru...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
22m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1591042132" data-format="short_date">Jun 01, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
22m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7593771-marvels-in-medicine-dr-karlan-on-breaking-down-gender-barriers-in-gynecologic-oncology"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep7: Marvels in Medicine: Dr. Karlan on Breaking Down Gender Barriers in Gynecologic Oncology
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Beth Y. Karlan, of UCLA David Geffen School of Medicine, shared the rewarding moments as well as challenges navigating the cancer space as a female oncologist, pivotal research she has been spearheaded that has lasting impacts on the field, and other developments in gynecologic cancers that are poised to change the landscape forever.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
35m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1590694237" data-format="short_date">May 28, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
35m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7589414-dr-burris-and-dr-graff-talk-covid-19-and-cancer-care-telemedicine-and-asco-initiatives"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep6: Dr. Burris and Dr. Graff Talk COVID-19 and Cancer Care, Telemedicine, and ASCO Initiatives
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Burris and Dr. Graff discuss how the COVID-19 pandemic has affected cancer care, the collaborative efforts made between Sarah Cannon Research Institute and HCA to increase access to investigational COVID-19 treatments, and the steps ASCO has taken to ensure its members’ professional education and well-being during this time.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
28m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1590433200" data-format="short_date">May 25, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
28m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7588303-fda-approval-insights-subcutaneous-daratumumab-in-multiple-myeloma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep5: FDA Approval Insights: Subcutaneous Daratumumab in Multiple Myeloma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of speaking with Maria-Victoria Mateos, MD, PhD, to discuss the FDA approval of the subcutaneous daratumumab formulation in multiple myeloma.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
19m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1590087537" data-format="short_date">May 21, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
19m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7585286-mcgregor-details-gu-treatment-guidelines-during-covid-19-pandemic"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep4: McGregor Details GU Treatment Guidelines During COVID-19 Pandemic
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. McGregor discussed the purpose of the guidelines, some of the main factors that influenced the recommendations in genitourinary cancers, and the impact of the pandemic on some of the most common treatment interventions such as immunotherapy, chemotherapy, and hormonal therapy, for patients with these malignancies. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
19m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1589824320" data-format="short_date">May 18, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
19m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7582309-fda-approval-insights-olaparib-bevacizumab-in-advanced-ovarian-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep3: FDA Approval Insights: Olaparib/Bevacizumab in Advanced Ovarian Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Dr. Herzog discusses the FDA approval of the combination of olaparib and bevacizumab as frontline maintenance therapy for patients with advanced ovarian cancer, the safety profile of the combination, and the clinical implications of the approval. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
18m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1589478216" data-format="short_date">May 14, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
18m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7579198-talking-tumors-exploring-management-strategies-in-multiple-myeloma"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep2: Talking Tumors: Exploring Management Strategies in Multiple Myeloma
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
This week, we spoke with Nina Shah, MD and Sandy Wong, MD, both of the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, to discuss the predictive value of minimal residual disease and the need for treatment in a patient with smoldering multiple myeloma. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
30m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1589214575" data-format="short_date">May 11, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
30m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7576709-making-headway-in-gi-malignancies-in-miami"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S3 Ep1: Making Headway in GI Malignancies in Miami
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We recently traveled to Miami, Florida for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from the Florida Society of Clinical Oncology discussed the novel agents that are generating excitement in advanced hepatocellular carcinoma and cholangiocarcinoma and the novel therapies and strategies that are propelling progress in gastric cancer. Moreover, pane...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
27m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1588879914" data-format="short_date">May 07, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
27m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7573847-the-uromigos-unveil-updates-and-insights-on-the-impact-of-covid-19-on-gu-cancers"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep50: The Uromigos Unveil Updates and Insights on the Impact of COVID-19 on GU Cancers
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of sitting down with members of Uromigos, a group of genitourinary cancer oncologists from all over the world who share their oncologic insights through their collaborative Twitter account and in the form of their own podcasts.  

In an effort to share some of the evolving knowledge about COVID-19 pandemic and how it is impacting the healthcare system on a global scale, the ...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
25m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1588617531" data-format="short_date">May 04, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
25m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7570989-marvels-in-medicine-gabriel-hortobagyi-on-challenging-historical-dogmas-in-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep49: Marvels in Medicine: Gabriel Hortobagyi on Challenging Historical Dogmas in Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Gabriel N. Hortobagyi, MD, of The University of Texas MD Anderson Cancer Center shares his journey in the development of anthracyclines and taxanes, biphosphonates, and gene therapies in breast cancer, some of the challenges he has encountered along the way and what he hopes to tackle in the rest of his monumental career. 	
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
39m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1588270377" data-format="short_date">Apr 30, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
39m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7567078-fda-approval-insights-sacituzumab-govitecan-in-metastatic-triple-negative-breast-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep48: FDA Approval Insights: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In our exclusive interview, Aditya Bardia, MD, of Massachusetts General Hospital Cancer Center, discusses the FDA approval of sacituzumab govitecan in metastatic triple-negative breast cancer, the implications of the approval, and ongoing research with the agent. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
13m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1588002628" data-format="short_date">Apr 27, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
13m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7564597-observing-optimal-treatment-strategies-in-ovarian-cancer-in-ohio"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep47: Observing Optimal Treatment Strategies in Ovarian Cancer in Ohio
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We recently traveled to Columbus, Ohio for a State of the Science Summit on Ovarian Cancer. At the meeting, faculty from The Ohio University Comprehensive Cancer Center–James, discussed the importance of performing genetic testing upon diagnosis, shared insight on the evolution of ovarian cancer therapeutics, and provided perspective on individualized approaches in the frontline setting.

Addit...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
38m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1587668786" data-format="short_date">Apr 23, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
38m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7561606-talking-tumors-treating-with-immunotherapy-and-targeted-therapy-in-lung-cancer"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep46: Talking Tumors: Treating With Immunotherapy and Targeted Therapy in Lung Cancer
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We recently traveled to Chicago, Illinois, for a State of the Science Summit™ on Lung Cancer. Jyoti D. Patel, MD, and Lawrence E. Feldman, MD, discuss second-line therapy in extensive-stage small cell lung cancer and the need for consolidative radiation, as well as the optimal sequence of therapy for a patient with non–small cell lung cancer who harbors a MET exon 14 mutation.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
38m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1587406730" data-format="short_date">Apr 20, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
38m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7558767-navigating-newfound-gu-treatment-considerations-in-the-context-of-covid-19"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep45: Navigating Newfound GU Treatment Considerations in the Context of COVID-19
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of sitting down with Guru P. Sonpavde, MD, the director of the Bladder Cancer Program and a physician at Dana-Farber Cancer Institute.

In our exclusive interview, Dr. Sonpavde discusses how the COVID-19 pandemic has impacted treatment decisions for patients with bladder cancer, specifically, as they relate to the dosing and scheduling of chemotherapy, immunotherapy, and tar...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
19m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1587061093" data-format="short_date">Apr 16, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
19m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7555475-physician-and-patient-perspectives-on-diagnosis-and-treatment-in-essential-thrombocythemia"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep44: Physician and Patient Perspectives on Diagnosis and Treatment in Essential Thrombocythemia
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
In this special edition of OncLive On Air, we collaborated with one of our sister brands, CURE, for an exclusive interview with Ruben Mesa, MD and his patient, Antje Hjerpe, who has been living with essential thrombocythemia for 35 years, to discuss Hjerpe&#39;s treatment course, the current state of treatment in ET and ongoing research efforts, and resources to educate physicians and patients on M...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
29m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1586808119" data-format="short_date">Apr 13, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
29m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7553006-homing-in-on-clinical-advances-in-hematologic-malignancies-in-chicago"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep43: Homing in on Clinical Advances in Hematologic Malignancies in Chicago
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We recently traveled to Chicago, Illinois for a State of the Science Summit™ on Hematologic Malignancies. At the meeting, faculty from Rush University Medical Center shed light on ongoing research that is poised to add new options to the armamentarium in myelofibrosis, highlighted the novel agents that have strengthened treatment options in non-Hodgkin lymphoma, and discussed treatment consider...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
28m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1586460540" data-format="short_date">Apr 09, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
28m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7549445-gaining-ground-in-genitourinary-malignancies-in-nashville"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36328212/75x75/c 75w, https://audioboom.com/i/36328212/150x150/c 150w, https://audioboom.com/i/36328212/300x300/c 300w, https://audioboom.com/i/36328212/600x600/c 600w, https://audioboom.com/i/36328212/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #193e68; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36328212/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep42: Gaining Ground in Genitourinary Malignancies in Nashville
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We recently traveled to Nashville, Tennessee for a State of the Science Summit™ on Genitourinary Malignancies. At the meeting, faculty from Vanderbilt-Ingram Cancer Center shared insight on recent developments in prostate cancer. Specifically, panelists discussed selection criteria for androgen receptor-directed agents in nonmetastatic castration-resistant prostate cancer and explained how a po...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
30m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1586196775" data-format="short_date">Apr 06, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
30m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7547727-talking-her2-targeted-therapy-with-dr-ajani"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36317312/75x75/c 75w, https://audioboom.com/i/36317312/150x150/c 150w, https://audioboom.com/i/36317312/300x300/c 300w, https://audioboom.com/i/36317312/600x600/c 600w, https://audioboom.com/i/36317312/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #081746; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36317312/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep41: Talking HER2-Targeted Therapy With Dr. Ajani
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of speaking with Jaffer Ajani, MD, who discussed some of the investigational HER2-targeted treatment strategies with trastuzumab, antibody-drug conjugates, and bispecific antibodies that are under investigation in gastrointestinal malignancies. Listen on to hear Ajani discuss some of the HER2-targeted strategies that are under exploration in gastric/GEJ cancer and colorectal...
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
18m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1585947000" data-format="short_date">Apr 03, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
18m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7547357-talking-her2-targeted-therapy-with-dr-chau"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36317312/75x75/c 75w, https://audioboom.com/i/36317312/150x150/c 150w, https://audioboom.com/i/36317312/300x300/c 300w, https://audioboom.com/i/36317312/600x600/c 600w, https://audioboom.com/i/36317312/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #081746; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36317312/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep40: Talking HER2-Targeted Therapy With Dr. Chau
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of speaking with Ian Chau, MD, FRCP, who discussed the state of HER2-directed therapy in gastric/gastroesophageal cancer. Listen on to hear Chau discuss HER2 testing in gastric/GEJ cancer and several HER2-targeted strategies under evaluation.
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
15m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1585926000" data-format="short_date">Apr 03, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
15m
</div>
</div>
</div>
</a></div>
<hr class="mvn mhs text-black-50 opacity-25">
<div class="card rounded-0 border-0 pas qa-audio-clip-overview" style="--bs-card-bg: transparent;">
<a class="text-decoration-none" href="/posts/7547355-talking-her2-targeted-therapy-with-dr-marshall"><div class="Episode-list-grid card-body pan">
<div class="l-flex align-items-baseline gap-2 gap-md-3">
<img srcset="https://audioboom.com/i/36317312/75x75/c 75w, https://audioboom.com/i/36317312/150x150/c 150w, https://audioboom.com/i/36317312/300x300/c 300w, https://audioboom.com/i/36317312/600x600/c 600w, https://audioboom.com/i/36317312/1400x1400/c 1400w" sizes="(max-width: 400px) 64px, 96px" style="background-color: #081746; max-width: 96px; width: 15cqw;" class="js-img-bg ratio-square rounded-1" loading="lazy" src="https://audioboom.com/i/36317312/1400x1400/c" />
<div class="vstack gap-1 my-auto">
<h5 class="text-line-clamp text-line-clamp-3 balanced-h fs-6 fs-5-lg fw-normal mb-0">
S2 Ep39: Talking HER2-Targeted Therapy With Dr. Marshall
</h5>
<div class="text-line-clamp text-line-clamp-3 balanced-p fs-8 text-muted text-break">
We had the pleasure of speaking with John L. Marshall, MD, who discussed the evolving treatment landscape of HER2-targeted treatment strategies in colorectal cancer. Listen on to hear Marshall discuss the necessity of identifying patients with HER2-positive colorectal cancer and the work being done to better elucidate effective targeted treatments for patients. 
</div>
<div class="text-muted df align-items-baseline gap-2 fs-8">
<span class="numeric-tabular d-sm-none">
9m
</span>
<span class="d-sm-none">
&bull;
</span>
<span><span class="js-time" data-epochtime="1585925100" data-format="short_date">Apr 03, 2020</span></span>
</div>
</div>
</div>
<div class="d-none d-sm-grid" style="justify-self: center; align-items: center;">
<div class="fs-8 numeric-tabular text-nowrap text-muted phs">
9m
</div>
</div>
</div>
</a></div>

</template></turbo-stream>
  <turbo-stream action="replace" target="audio_clips_pagination"><template><turbo-frame loading="lazy" id="audio_clips_pagination" src="/channels/4965461-onclive-on-air.turbo_stream?list=1&amp;page=16"><div aria-hidden="true" class="card rounded-0 border-0 border-bottom">
<div class="card-body df align-items-center placeholder-glow text-black-50">
<div class="w-100">
<h5>
<div class="placeholder col-6"></div>
</h5>
<div class="placeholder placeholder-sm" style="width:15ch"></div>
</div>
<div class="mla">
<span class="placeholder placeholder-sm" style="width:4ch"></span>
</div>
</div>
</div>
<div aria-hidden="true" class="card rounded-0 border-0 border-bottom">
<div class="card-body df align-items-center placeholder-glow text-black-50">
<div class="w-100">
<h5>
<div class="placeholder col-6"></div>
</h5>
<div class="placeholder placeholder-sm" style="width:15ch"></div>
</div>
<div class="mla">
<span class="placeholder placeholder-sm" style="width:4ch"></span>
</div>
</div>
</div>
<div aria-hidden="true" class="card rounded-0 border-0 border-bottom">
<div class="card-body df align-items-center placeholder-glow text-black-50">
<div class="w-100">
<h5>
<div class="placeholder col-6"></div>
</h5>
<div class="placeholder placeholder-sm" style="width:15ch"></div>
</div>
<div class="mla">
<span class="placeholder placeholder-sm" style="width:4ch"></span>
</div>
</div>
</div>
<div aria-hidden="true" class="card rounded-0 border-0 border-bottom">
<div class="card-body df align-items-center placeholder-glow text-black-50">
<div class="w-100">
<h5>
<div class="placeholder col-6"></div>
</h5>
<div class="placeholder placeholder-sm" style="width:15ch"></div>
</div>
<div class="mla">
<span class="placeholder placeholder-sm" style="width:4ch"></span>
</div>
</div>
</div>
<div aria-hidden="true" class="card rounded-0 border-0 border-bottom">
<div class="card-body df align-items-center placeholder-glow text-black-50">
<div class="w-100">
<h5>
<div class="placeholder col-6"></div>
</h5>
<div class="placeholder placeholder-sm" style="width:15ch"></div>
</div>
<div class="mla">
<span class="placeholder placeholder-sm" style="width:4ch"></span>
</div>
</div>
</div>
<div class="visually-hidden">
<a href="/channels/4965461-onclive-on-air?list=1&amp;page=16">next page</a>
</div>
</turbo-frame></template></turbo-stream>
